InvestorsHub Logo
Followers 19
Posts 628
Boards Moderated 0
Alias Born 04/17/2013

Re: Biobillionair post# 217874

Sunday, 10/06/2019 12:15:44 PM

Sunday, October 06, 2019 12:15:44 PM

Post# of 425915
BIO,

Thank you for updating submissions by both parties concerning the Generic lawsuit from Apr. to Oct. 4,2019 thru Pacer Account....

IMO, PACER documents communication between Amarin and the Generic filers...

1. Generics are requesting that Amarin forward to them the full March,2019 SDNA submittal and requested LABEL.... they are also requesting that AMARIN forward any further communication with the FDA thru Oct. 4th... this request to see if any change in LABEL has been submitted by AMARIN to FDA...

2. Amarin is requesting that the Generics forward any communication with the FDA up thru OCT.4TH to possibly see if FDA is corresponding inappropriately with Generics concerning SDNA and LABEL....

Both parties keeping tabs on each other.....

This should not interfere with the rulings by the court on motions submitted by both parties on AUGUST,30,2019 and AMARINS reply on SEPTEMBER 1,2019 concerning "WRITTEN DESCRIPTION".... the court can rule anytime as one does not have anything to do with the other.... either party can initiate a new court case if interference could be claimed that caused the ADCOM and new PDUF date late December 2019. Bio is trying to connect the dots, but no proof as of yet.....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News